Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Dafeng Guo, Yu Yu, Binyu Long, Ping Deng, Dongzhi Ran, Lei Han, Jiecheng Zheng & Zongjie Gan. (2022) Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2512-2529.
Read now
Read now
Ludovica Lospinoso Severini, Francesca Ghirga, Francesca Bufalieri, Deborah Quaglio, Paola Infante & Lucia Di Marcotullio. (2020) The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma. Expert Opinion on Therapeutic Targets 24:11, pages 1159-1181.
Read now
Read now
Shabir Ahmad Ganai. (2016) Histone deacetylase inhibitor pracinostat in doublet therapy: a unique strategy to improve therapeutic efficacy and to tackle herculean cancer chemoresistance. Pharmaceutical Biology 54:9, pages 1926-1935.
Read now
Read now
Shabir Ahmad Ganai. (2016) Histone deacetylase inhibitor givinostat: the small-molecule with promising activity against therapeutically challenging haematological malignancies. Journal of Chemotherapy 28:4, pages 247-254.
Read now
Read now
Zlatka Georgieva Dobreva, Boncho Grigorov Grigorov & Spaska Angelova Stanilova. (2016) Suppression of IL-12p40-related regulatory cytokines by suberoylanilide hydroxamic acid an inhibitor of histone deacetylases. Immunopharmacology and Immunotoxicology 38:4, pages 281-285.
Read now
Read now
Susmitha Apuri & Lubomir Sokol. (2016) An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin’s lymphoma. Expert Opinion on Investigational Drugs 25:6, pages 687-696.
Read now
Read now
A Tedjaseputra, S Galli, M Ibrahim, CN Harrison & DP McLornan. (2016) Histone deacetylase inhibitors in myeloproliferative neoplasms: current roles and future prospects. Expert Opinion on Orphan Drugs 4:4, pages 417-427.
Read now
Read now
Fabiana AS Brandão, Lorena S Derengowski, Patrícia Albuquerque, André M Nicola, Ildinete Silva-Pereira & Marcio J Poças-Fonseca. (2015) Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes. Virulence 6:6, pages 618-630.
Read now
Read now
Shabir Ahmad Ganai, Shashwath Malli Kalladi & Vijayalakshmi Mahadevan. (2015) HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells. Journal of Biomolecular Structure and Dynamics 33:6, pages 1185-1197.
Read now
Read now
Stefan Swierczynski, Eckhard Klieser, Romana Illig, Beate Alinger-Scharinger, Tobias Kiesslich & Daniel Neureiter. (2015) Histone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases. Expert Opinion on Biological Therapy 15:5, pages 651-664.
Read now
Read now
Lei Zhang & Wenfang Xu. (2015) Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1). Expert Opinion on Therapeutic Patents 25:2, pages 237-240.
Read now
Read now
Shabir Ahmad Ganai, Karthi Shanmugam & Vijayalakshmi Mahadevan. (2015) Energy-optimised pharmacophore approach to identify potential hotspots during inhibition of Class II HDAC isoforms. Journal of Biomolecular Structure and Dynamics 33:2, pages 374-387.
Read now
Read now
Articles from other publishers (41)
Octavia-Laura Moldovan, Alexandra Sandulea, Ioana-Andreea Lungu, Șerban Andrei Gâz & Aura Rusu. (2023) Identification of Some Glutamic Acid Derivatives with Biological Potential by Computational Methods. Molecules 28:10, pages 4123.
Crossref
Crossref
Rubi Roy, Tasnim Ria, Debapriya RoyMahaPatra & Ugir Hossain Sk. (2023) Single Inhibitors versus Dual Inhibitors: Role of HDAC in Cancer. ACS Omega 8:19, pages 16532-16544.
Crossref
Crossref
Asmita Parab, Lokesh Kumar Bhatt & Abdelwahab Omri. (2023) Targeting Epigenetic Mechanisms: A Boon for Cancer Immunotherapy. Biomedicines 11:1, pages 169.
Crossref
Crossref
Anna-Maria Barciszewska, Agnieszka Belter, Iwona Gawrońska, Małgorzata Giel-Pietraszuk & Mirosława Z. Naskręt-Barciszewska. (2022) Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines. Frontiers in Oncology 12.
Crossref
Crossref
Eftiola Pojani & Daniela Barlocco. (2022) Selective Inhibitors of Histone Deacetylase 10 (HDAC-10). Current Medicinal Chemistry 29:13, pages 2306-2321.
Crossref
Crossref
Aaron Kolski-Andreaco, Corina M. Balut, Claudia A. Bertuccio, Annette S. Wilson, William M. Rivers, Xiaoning Liu, Robin E. Gandley, Adam C. Straub, Michael B. Butterworth, David Binion & Daniel C. Devor. (2022) Histone deacetylase inhibitors (HDACi) increase expression of KCa2.3 (SK3) in primary microvascular endothelial cells. American Journal of Physiology-Cell Physiology 322:3, pages C338-C353.
Crossref
Crossref
Xiaopeng Peng, Ling Li, Jingxuan Chen, Yichang Ren, Jin Liu, Ziwen Yu, Hao Cao & Jianjun Chen. (2022) Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma. Journal of Medicinal Chemistry 65:3, pages 2434-2457.
Crossref
Crossref
Yingying Liang & Sevin Turcan. (2022) Epigenetic Drugs and Their Immune Modulating Potential in Cancers. Biomedicines 10:2, pages 211.
Crossref
Crossref
Jingxi Xu & Jiangtao Li. (2022) Construction of a three commitment points for S phase entry cell cycle model and immune-related ceRNA network to explore novel therapeutic options for psoriasis. Mathematical Biosciences and Engineering 19:12, pages 13483-13525.
Crossref
Crossref
Chao Ma, Mohammed S. Taghour, Amany Belal, Ahmed B. M. Mehany, Naglaa Mostafa, Ahmed Nabeeh, Ibrahim H. Eissa & Ahmed A. Al-Karmalawy. (2021) Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR Studies. Frontiers in Chemistry 9.
Crossref
Crossref
Tanya J. Applegate, Greta M. Krafsur, June A. Boon, Hui Zhang, Min Li, Timothy N. Holt, S. Kelly Ambler, Benjamin A. Abrams, Daniel L. Gustafson, Karsten Bartels, Franklyn B. Garry, Kurt R. Stenmark & R. Dale Brown. (2021) Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension. Frontiers in Physiology 12.
Crossref
Crossref
Ricardo Ribeiro Gama, Lidia Maria Rebolho Batista Arantes, Bruna Pereira Sorroche, Pedro De Marchi, Matias Eliseo Melendez, Raiany Santos Carvalho, Marcos Alves de Lima, André Luiz Vettore & André Lopes Carvalho. (2021) Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid. Scientific Reports 11:1.
Crossref
Crossref
Xiaopeng Peng, Jingxuan Chen, Ling Li, Zhiqiang Sun, Jin Liu, Yichang Ren, Junli Huang & Jianjun Chen. (2021) Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents. Journal of Medicinal Chemistry 64:12, pages 8447-8473.
Crossref
Crossref
Agnieszka E. Zając, Sylwia Kopeć, Bartłomiej Szostakowski, Mateusz J. Spałek, Michał Fiedorowicz, Elżbieta Bylina, Paulina Filipowicz, Anna Szumera-Ciećkiewicz, Andrzej Tysarowski, Anna M. Czarnecka & Piotr Rutkowski. (2021) Chondrosarcoma-from Molecular Pathology to Novel Therapies. Cancers 13:10, pages 2390.
Crossref
Crossref
Michèle J. Hoffmann, Sarah Meneceur, Katrin Hommel, Wolfgang A. Schulz & Günter Niegisch. (2021) Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells. Genes 12:2, pages 260.
Crossref
Crossref
Zhichao Xue, Vivian Wai Yan Lui, Yongshu Li, Lin Jia, Chanping You, Xin Li, Wenying Piao, Hui Yuan, Pek Lan Khong, Kwok Wai Lo, Lydia Wai Ting Cheung, Victor Ho Fan Lee, Anne Wing Mui Lee, Sai Wah Tsao & Chi Man Tsang. (2020) Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Donglu Wu, Ye Qiu, Yunshuang Jiao, Zhidong Qiu & Da Liu. (2020) Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy. Frontiers in Oncology 10.
Crossref
Crossref
Masakazu Hamada & Yoshiaki Yura. (2020) Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer. International Journal of Molecular Sciences 21:19, pages 7073.
Crossref
Crossref
Flávia Alves Verza, Umashankar Das, Ana Lúcia Fachin, Jonathan R. Dimmock & Mozart Marins. (2020) Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy. Cancers 12:6, pages 1664.
Crossref
Crossref
Thayse Pinheiro da Costa, Marcia Cury El-Cheikh & Katia Carneiro. (2020) Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders. Journal of Immunology Research 2020, pages 1-19.
Crossref
Crossref
Ying Wu, Lei Wang, Yahui Huang, Shuqiang Chen, Shanchao Wu, Guoqiang Dong & Chunquan Sheng. (2019) Nicotinamide Phosphoribosyltransferase (NAMPT) Is a New Target of Antitumor Agent Chidamide. ACS Medicinal Chemistry Letters 11:1, pages 40-44.
Crossref
Crossref
Hassell. (2019) Histone Deacetylases and their Inhibitors in Cancer Epigenetics. Diseases 7:4, pages 57.
Crossref
Crossref
Kim, Kwon, Jung, Kim & Jeoung. (2019) FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions. International Journal of Molecular Sciences 20:19, pages 4964.
Crossref
Crossref
Doan Thanh Hieu, Duong Tien Anh, Pham‐The Hai, Nguyen Thi Thuan, Le‐Thi‐Thu Huong, Eun Jae Park, A. Young Ji, Jong Soon Kang, Phan Thi Phuong Dung, Sang‐Bae Han & Nguyen‐Hai Nam. (2019)
Quinazolin‐4(3
H
)‐one‐Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity
. Chemistry & Biodiversity 16:4.
Crossref
Crossref
Florian Schmitt, Lisa Gosch, Alexandra Dittmer, Matthias Rothemund, Thomas Mueller, Rainer Schobert, Bernhard Biersack, Andrea Volkamer & Michael Höpfner. (2019) Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function. International Journal of Molecular Sciences 20:2, pages 383.
Crossref
Crossref
Yahui Huang, Guoqiang Dong, Huanqiu Li, Na Liu, Wannian Zhang & Chunquan Sheng. (2018) Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections. Journal of Medicinal Chemistry 61:14, pages 6056-6074.
Crossref
Crossref
Amit Singh, Anupam Bishayee & Abhay Pandey. (2018) Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy. Nutrients 10:6, pages 731.
Crossref
Crossref
Margarite D. Matossian, Hope E. Burks, Steven Elliott, Van T. Hoang, Annie C. Bowles, Rachel A. Sabol, Bruce A. Bunnell, Elizabeth C. Martin, Matthew E. Burow & Bridgette M. Collins-Burow. (2018) Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model. Oncoscience 5:3-4, pages 99-108.
Crossref
Crossref
Wei Chen, Guoqiang Dong, Ying Wu, Wannian Zhang, Chaoyu Miao & Chunquan Sheng. (2017) Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery. ACS Medicinal Chemistry Letters 9:1, pages 34-38.
Crossref
Crossref
Shabir Ahmad Ganai, Ehsaan Abdullah, Romana Rashid & Mohammad Altaf. (2017) Combinatorial In Silico Strategy towards Identifying Potential Hotspots during Inhibition of Structurally Identical HDAC1 and HDAC2 Enzymes for Effective Chemotherapy against Neurological Disorders. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Yong Zhu, Xin Chen, Ting Ran, Jiaqi Niu, Shuang Zhao, Tao Lu & Weifang Tang. (2017) Design, synthesis and biological evaluation of urea-based benzamides derivatives as HDAC inhibitors. Medicinal Chemistry Research 26:11, pages 2879-2888.
Crossref
Crossref
Maha S. Al-Keilani & Nour A. Al-Sawalha. (2017) Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms. Chemical Research in Toxicology 30:10, pages 1767-1777.
Crossref
Crossref
Guoqiang Dong, Wei Chen, Xia Wang, Xinglin Yang, Tianying Xu, Pei Wang, Wannian Zhang, Yu Rao, Chaoyu Miao & Chunquan Sheng. (2017) Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors. Journal of Medicinal Chemistry 60:19, pages 7965-7983.
Crossref
Crossref
Tran Thi Lan Huong, Le Van Cuong, Pham Thu Huong, Tran Phuong Thao, Le-Thi-Thu Huong, Phan Thi Phuong Dung, Dao Thi Kim Oanh, Nguyen Thi Mai Huong, Hoang-Van Quan, Tran Khac Vu, Jisung Kim, Jae-Hee Lee, Sang-Bae Han, Pham-The Hai & Nguyen-Hai Nam. (2017) Exploration of some indole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents. Chemical Papers 71:9, pages 1759-1769.
Crossref
Crossref
Yekaterina Kori, Simone Sidoli, Zuo-Fei Yuan, Peder J. Lund, Xiaolu Zhao & Benjamin A. Garcia. (2017) Proteome-wide acetylation dynamics in human cells. Scientific Reports 7:1.
Crossref
Crossref
Iván Cheng-Sánchez, Cristina García-Ruiz, Guillermo A. Guerrero-Vásquez & Francisco Sarabia. (2017) An Olefin Cross-Metathesis Approach to Depudecin and Stereoisomeric Analogues. The Journal of Organic Chemistry 82:9, pages 4744-4757.
Crossref
Crossref
Bhatia Ravi Kant, Bhatia Shashi Kant, Bhalla Tek Chand & Bhatt Arvind Kumar. 2017. Microbial Applications Vol.2. Microbial Applications Vol.2
169
184
.
Maria Pinkerneil, Michèle J. Hoffmann, Hella Kohlhof, Wolfgang A. Schulz & Günter Niegisch. (2016) Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines. Targeted Oncology 11:6, pages 783-798.
Crossref
Crossref
Zarko V. Boskovic, Melissa M. Kemp, Allyson M. Freedy, Vasanthi S. Viswanathan, Marius S. Pop, Jason H. Fuller, Nicole M. Martinez, Samuel O. Figueroa Lazú, Jiyoung A. Hong, Timothy A. Lewis, Daniel Calarese, James D. Love, Amedeo Vetere, Steven C. Almo, Stuart L. Schreiber & Angela N. Koehler. (2016) Inhibition of Zinc-Dependent Histone Deacetylases with a Chemically Triggered Electrophile. ACS Chemical Biology 11:7, pages 1844-1851.
Crossref
Crossref
Anna Leonidova, Cristina Mari, Christine Aebersold & Gilles Gasser. (2016) Selective Photorelease of an Organometallic-Containing Enzyme Inhibitor. Organometallics 35:6, pages 851-854.
Crossref
Crossref
Elizabeth E. Hull, McKale R. Montgomery & Kathryn J. Leyva. (2016) HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases. BioMed Research International 2016, pages 1-15.
Crossref
Crossref